Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells
- 1 January 1999
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 3 (1) , 74-81
- https://doi.org/10.1016/s1091-255x(99)80012-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Enhanced Expression of TGF-βs and Their Receptors in Human Acute PancreatitisAnnals of Surgery, 1998
- Overexpression of the Epidermal Growth Factor Receptor Family in Gastric Cancer Suggests a Role in Tumor PathogenesisDigestive Surgery, 1997
- Modulation of apoptosis by the widely distributed Bcl-2 homologue BakNature, 1995
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994
- BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with BaxNature, 1994
- Prognosis in Carcinoma of the PancreasDigestive Surgery, 1994
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.Journal of Clinical Investigation, 1992